Get started
Author

Randall T. Schapiro

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
2009 · Andrew D Goodman, Theodore R Brown, et al. · The Lancet · 551
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
2010 · Andrew D. Goodman, Theodore R. Brown, et al. · Annals of Neurology · 373
Dose comparison trial of sustained-release fampridine in multiple sclerosis
2008 · A. D. Goodman, T. R. Brown, et al. · Neurology · 176
Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis
1998 · Richard P. Di Fabio, Judy Soderberg, et al. · Archives of Physical Medicine and Rehabilitation · 136
Symptom management in multiple sclerosis
1994 · Randall T. Schapiro · Annals of Neurology · 103
Relationship of the Antispasticity Effect of Tizanidine to Plasma Concentration in Patients With Multiple Sclerosis
1997 · P. W. Nance, W. A. Sheremata, et al. · Archives of Neurology · 72
Symptoms and physical activity behavior in individuals with multiple sclerosis
2008 · Robert W. Motl, Erin M. Snook, et al. · Research in Nursing & Health · 71
Infectious Mononucleosis in Patients Aged 40 to 72 Years
1983 · CHARLES A. HORWITZ, WERNER HENLE, et al. · Medicine · 69
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials
2015 · Andrew D Goodman, Francois Bethoux, et al. · Multiple Sclerosis Journal · 55
Managing symptoms of multiple sclerosis
2005 · Randall T. Schapiro · Neurologic Clinics · 50
Role of Cardiovascular Fitness in Multiple Sclerosis: A Pilot Study
1988 · R. T. Schapiro, J. H. Petajan, et al. · Neurorehabilitation and neural repair · 39
Field testing of a minimal record of disability in multiple sclerosis: The United States and Canada
2009 · Nicholas G. LaRocca, Labe C. Scheinberg, et al. · Acta Neurologica Scandinavica · 37
Managing the Symptoms of Multiple Sclerosis
2006 · Randall T. Schapiro · CRC Press eBooks · 35
A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis
2014 · Andrew D. Goodman, Theodore R. Brown, et al. · International Journal of MS Care · 31
PDF
Symptomatic therapy of multiple sclerosis
1994 · Randall T. Schapiro, Sara L. Langer · Current Opinion in Neurology · 23
Pharmacologic Options for the Management of Multiple Sclerosis Symptoms
2002 · Randall T. Schapiro · Neurorehabilitation and neural repair · 22
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis
2001 · Randall T. Schapiro · Current Neurology and Neuroscience Reports · 22
Current Issues in Spasticity Management
1997 · Robert R. Young, Murat Emre, et al. · The Neurologist · 22
Multiple Sclerosis: A Rehabilitation Approach to Management
1991 · Randall T. Schapiro · 20
Primary CNS lymphoma presenting as multiple sclerosis. A case study.
1989 · G P Bender, R T Schapiro · PubMed · 17
The symptomatic management of multiple sclerosis
2009 · RandallT Schapiro · Annals of Indian Academy of Neurology · 15
The Current Management of Multiple Sclerosis
1984 · RANDALL T. SCHAPIRO, STANLEY vanden NOORT, et al. · Annals of the New York Academy of Sciences · 11
Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists
2009 · Robert J. Lipsy, Randall T. Schapiro, et al. · Journal of Managed Care Pharmacy · 10
PDF
Neurological Impairment as Confounder or Moderater of Association Between Symptoms and Physical Activity in Multiple Sclerosis
2008 · Robert W. Motl, Erin M. Snook, et al. · International Journal of MS Care · 8
The Rehabilitation of Multiple Sclerosis
1990 · R. T. Schapiro · Neurorehabilitation and neural repair · 8
Works count: 37
Citation count: 1,995
H-index: 19
I10-index: 23
Year
Topic
Type